Table 2.
Univariable analysis of potential risk factors for suicide risk
| Characteristics |
Univariable ordinal logistic regression |
||
| OR (95%CI) | P value | ||
| Sociodemographic | |||
| Sex | 0.116 | ||
| Male | 1.00 | ||
| Female | 1.85 (0.86-3.98) | ||
| Age (yr) | 0.96 (0.93-0.99) | 0.026a | |
| Educational level | 0.609 | ||
| Uneducated | 1.00 | ||
| 1-6 yr | 2.03 (0.43-9.56) | ||
| 7-9 yr | 1.90 (0.38-9.57) | ||
| 10-12 yr | 3.01 (0.58-15.70) | ||
| 13 yr or more | 1.07 (0.13-8.53) | ||
| Marital status | 0.316 | ||
| Single | 1.00 | ||
| Married | 0.63 (0.20-1.93) | ||
| Divorced/Separated/Widowed | 1.60 (0.70-3.66) | ||
| Occupation | 0.272 | ||
| Unemployed | 1.00 | ||
| Employed | 0.60 (0.28-1.30) | ||
| Other | 0.29 (0.04-2.42) | ||
| Personal annual income (US dollars1) | 1.00 (1.00-1.00) | 0.918 | |
| Household annual income (US dollars1) | 1.00 (1.00-1.00) | 0.881 | |
| Debt | 0.598 | ||
| No | 1.00 | ||
| Yes | 0.81 (0.37-1.78) | ||
| Mental illness | |||
| Major depressive episode: Current | < 0.001a | ||
| No | 1.00 | ||
| Yes | 43.62 (8.51-223.65) | ||
| ICD10: schizophrenia type | 0.638 | ||
| Paranoid | 1.00 | ||
| Other | 1.19 (0.58-2.44) | ||
| Duration of schizophrenia (years) | 1.00 (0.96-1.05) | 0.877 | |
| Medication in previous month | |||
| Clozapine | 0.565 | ||
| Not received | 1.00 | ||
| Received | 1.23 (0.61-2.45) | ||
| Risperidone | 0.683 | ||
| Not received | 1.00 | ||
| Received | 1.20 (0.51-2.84) | ||
| Fluphenazine | 0.583 | ||
| Not received | 1.00 | ||
| Received | 0.80 (0.37-1.75) | ||
| Chlorpromazine | 0.151 | ||
| Not received | 1.00 | ||
| Received | 0.54 (0.24-1.25) | ||
| Haloperidol | 0.603 | ||
| Not received | 1.00 | ||
| Received | 0.67 (0.14-3.08) | ||
| Haloperidol decanoate | 0.685 | ||
| Not received | 1.00 | ||
| Received | 1.27 (0.40-4.08) | ||
| Trifluoperazine | 0.143 | ||
| Not received | 1.00 | ||
| Received | 0.50 (0.20-1.27) | ||
| Perphenazine | 0.565 | ||
| Not received | 1.00 | ||
| Received | 1.23 (0.61-2.45) | ||
| AMA2 | 0.234 | ||
| Not received | 1.00 | ||
| Received | 0.29 (0.04-2.25) | ||
| Clonazepam | 0.897 | ||
| Not received | 1.00 | ||
| Received | 0.90 (0.19-4.30) | ||
| Lorazepam | 0.47 | ||
| Not received | 1.00 | ||
| Received | 1.65 (0.42-6.45) | ||
| Diazepam | 0.445 | ||
| Not received | 1.00 | ||
| Received | 0.65 (0.21-1.97) | ||
| Fluoxetine | < 0.001a | ||
| Not received | 1.00 | ||
| Received | 26.77 (7.53-95.20) | ||
| Sertraline | 0.443 | ||
| Not received | 1.00 | ||
| Received | 2.62 (0.22-30.46) | ||
| Lithium carbonate | 0.01a | ||
| Not received | 1.00 | ||
| Received | 3.09 (1.31-7.29) | ||
| Depakine | 0.4 | ||
| Not received | 1.00 | ||
| Received | 1.67 (0.51-5.51) | ||
| Artane | 0.685 | ||
| Not received | 1.00 | ||
| Received | 0.79 (0.25-2.52) | ||
| Score for medication compliance | 0.244 | ||
| Less than 5 | 1.00 | ||
| 5 or more | 1.50 (0.76-2.95) | ||
| History of treatment | |||
| Electroconvulsive therapy | 0.242 | ||
| No | 1.00 | ||
| Yes | 1.52 (0.75-3.06) | ||
| Psychotherapy | 0.492 | ||
| No | 1.00 | ||
| Yes | 1.51 (0.46-4.94) | ||
| Other treatment | 0.66 | ||
| No | 1.00 | ||
| Yes | 0.62 (0.07-5.21) | ||
| Treatment satisfaction (score) | 0.99 (0.83-1.18) | 0.911 | |
| Other indices | |||
| Charlson Comorbidity index (score) | 1.10 (0.95-1.26) | 0.195 | |
| Psychosocial score (score) | 0.93 (0.86-1.00) | 0.046a | |
| Weapons and toxic chemicals accessibility score (score) | 0.98 (0.95-1.02) | 0.438 | |
1
One US dollar approximately equals 32 Thai baht.
2
AMA is a combined medication: amobarbital 50 mg and chlorpromazine HCl 25 mg.
a
P < 0.05. OR: Odds ratio; CI: Confidence interval.